These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2177600)

  • 1. [Anti-HVC antibodies and recipients of blood products: preliminary results of a prospective survey performed at a Parisian C. H. U].
    Lunel F; Azar N; Fournel JJ; Valla D; Foucault C; Habibi B; Jaulmes D; Perrin M; Opolon P; Huraux JM
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):361-7. PubMed ID: 2177600
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-HCV antibodies and transfusion recipients. Bibliographic data and current knowledge].
    Couroucé AM
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):335-8. PubMed ID: 2177594
    [No Abstract]   [Full Text] [Related]  

  • 3. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
    Janot C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
    Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-HCV antibodies and post-transfusional non-A, non-B hepatitis].
    Smilovici W; Trepo C; Marinière AM; Ducos J
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):359-60. PubMed ID: 2177599
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
    Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E
    Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 9. Is anti-HCV blood donor screening useful?
    Fiedler H
    Lancet; 1990 Nov; 336(8724):1193. PubMed ID: 1978051
    [No Abstract]   [Full Text] [Related]  

  • 10. Infectivity of blood seropositive for hepatitis C virus antibodies.
    van der Poel CL; Reesink HW; Schaasberg W; Leentvaar-Kuypers A; Bakker E; Exel-Oehlers PJ; Lelie PN
    Lancet; 1990 Mar; 335(8689):558-60. PubMed ID: 1968574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serological study on hepatitis C (HCV) in 4371 blood donors].
    Arnone M; Pinducciu G; Usai M; Pitzus F; Pintus L
    Ann Ig; 1990; 2(5):353-8. PubMed ID: 1715726
    [No Abstract]   [Full Text] [Related]  

  • 13. HCV infection and its clinical features in recipients of blood screened for HCV (C100-3) antibody.
    Ito S; Honda H; Hibino S; Nii C; Kamamura M; Nishikado T; Fujikawa H; Saijo T; Okamura S; Shimizu I
    J Gastroenterol Hepatol; 1994; 9(1):19-25. PubMed ID: 8155861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second generation anti-HCV test: seroprevalence in hemodialysis patients and blood donors.
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Transplant Proc; 1992 Dec; 24(6):2648-9. PubMed ID: 1334595
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver disease in anti-hepatitis C virus-positive Norwegian blood donors.
    Nordøy I; Schrumpf E; Elgjo K; Flesland O; Andersen Glende J; Orjasaeter H; Siebke JC
    Scand J Gastroenterol; 1994 Jan; 29(1):77-81. PubMed ID: 8128181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-HCV-screening of blood donors in Gothenburg--the second generation tests are more specific].
    Lindholm A; Shev S; Norkrans G; Iwarson S; Hermodsson S
    Lakartidningen; 1991 Oct; 88(42):3475-6. PubMed ID: 1658502
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-hepatitis C antibodies in prospectively followed-up transfused patients.
    Couroucé AM; Jullien AM; Vedrenne JB; Habibi B
    Vox Sang; 1990; 58(3):226-7. PubMed ID: 2111065
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-HVC antibodies and raw-material plasma: reflections and strategy].
    Avenard G; Maquin A; Schoeffter C; Mangin C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):351-4. PubMed ID: 2177597
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern Italy.
    Elia GF; Magnani G; Belli L; Formentini A; Iacono S; Marchelli S; Pincolini S; Lecchini R; Bernuzzi G; Fiaccadori F
    Infection; 1991; 19(5):336-9. PubMed ID: 1666064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.